Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Castellani

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Expert Review of Gastroenterology & Hepatology|November 24, 2015
Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infectionMarc Bourlière, Xavier Adhoute, Christelle Ansaldi, et al.
Clinics and Research in Hepatology and Gastroenterology|January 18, 2012
Chronic hepatitis C: treatments of the futureMarc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
Future treatment of patients with HCV cirrhosisMarc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|September 18, 2016
Double guidewire endoscopic technique, a major evolution in endoscopic retrograde cholangiopancreatography: Results of a retrospective study with historical controls comparing two therapeutic sequential strategiesArthur Laquiere, Etienne Desilets, Arthur Belle, et al.
World Journal of Hepatology|June 23, 2016
Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatmentsXavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Plos One|March 14, 2012
Detection of IL28B SNP DNA from buccal epithelial cells, small amounts of serum, and dried blood spotsPhilippe Halfon, Denis Ouzan, Hacène Khiri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 14, 2016
Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failureSofiane Mohamed, Marc Bourliere, Souad Benali, et al.
Gastroenterologie Clinique Et Biologique|May 31, 2006
[Sarcoidosis following pegylated interferon therapy: two cases]Souad Benali, Christian Boustière, Paul Castellani, et al.
European Journal of Gastroenterology & Hepatology|July 31, 2024
Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life studyXavier Adhoute, Alexia Gonzalez, Thomas Levi-Strauss, et al.
European Journal of Gastroenterology & Hepatology|September 9, 2011
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virusPhilippe Halfon, Marc Bourliere, Denis Ouzan, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Expert Review of Gastroenterology & Hepatology|November 24, 2015
Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infectionMarc Bourlière, Xavier Adhoute, Christelle Ansaldi, et al.
Clinics and Research in Hepatology and Gastroenterology|January 18, 2012
Chronic hepatitis C: treatments of the futureMarc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
Future treatment of patients with HCV cirrhosisMarc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|September 18, 2016
Double guidewire endoscopic technique, a major evolution in endoscopic retrograde cholangiopancreatography: Results of a retrospective study with historical controls comparing two therapeutic sequential strategiesArthur Laquiere, Etienne Desilets, Arthur Belle, et al.
World Journal of Hepatology|June 23, 2016
Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatmentsXavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, et al.
Plos One|March 14, 2012
Detection of IL28B SNP DNA from buccal epithelial cells, small amounts of serum, and dried blood spotsPhilippe Halfon, Denis Ouzan, Hacène Khiri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 14, 2016
Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failureSofiane Mohamed, Marc Bourliere, Souad Benali, et al.
Gastroenterologie Clinique Et Biologique|May 31, 2006
[Sarcoidosis following pegylated interferon therapy: two cases]Souad Benali, Christian Boustière, Paul Castellani, et al.
European Journal of Gastroenterology & Hepatology|July 31, 2024
Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life studyXavier Adhoute, Alexia Gonzalez, Thomas Levi-Strauss, et al.
European Journal of Gastroenterology & Hepatology|September 9, 2011
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virusPhilippe Halfon, Marc Bourliere, Denis Ouzan, et al.
Pageof 4